| 1133126-09-6 |
|
6-allyl-3-benzyl-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one |
C14H13N5O |
| 1133126-16-5 |
|
3-benzyl-6-[2-(1-pyrrolidinyl)ethyl]-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one |
C17 H20 N6 O |
| 1133126-78-9 |
|
1-benzyl-5-({[4-(2-pyridinyl)-1-piperazinyl]acetyl}amino)-1H-1,2,3-triazole-4-carboxamide |
C21H24N8O2 |
| 1133126-91-6 |
|
5-{[(1H-benzimidazol-2-ylthio)acetyl]amino}-1-benzyl-1H-1,2,3-triazole-4-carboxamide |
C19H17N7O2S |
| 1133130-12-7 |
|
ethyl 2-{[(cyclopropylamino)carbothioyl]amino}-2',4-bithiophene-3-carboxylate |
C15H16N2O2S3 |
| 113314-04-8 |
|
2(1H)-Quinoxalinone, 3-[2-hydroxy-1-[2-(2-methylphenyl)hydrazinylidene]ethyl] |
C17H16N4O2 |
| 1133149-41-3 |
2,3-双[(2R,5R)-2,5-二甲基膦酰基]-N-[3,5-双(三氟甲基)-苯基]马来酰亚胺 |
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-[3,5-bis(trifluoromethyl)phenyl]-1H-pyrrole-2,5-dione |
C24H27F6NO2P2 |
| 1133153-38-4 |
DNV-II iMpurity 2 |
DNV-II iMpurity 2 |
C25H35N3O7S |
| 113317-61-6 |
(±)-尼古地平盐酸盐 |
(+/-)-NIGULDIPINE HYDROCHLORIDE |
C36H40ClN3O6 |
| 113318-05-1 |
LYS-LEU-LYS-LYS-THR-GLU-THR-GLN-GLU-LYS-ASN-PRO-LEU-PRO-SER-LYS-GLU-THR-ILE-GLU-GLN-GLU-LYS |
THYMOSIN BETA4 (16-38) |
C118H204N32O41 |
| 113318-71-1 |
|
1H-Tetrazole-1-propanoic acid, 5-[7-oxo-6-[(triphenylmethyl)amino]-4-thia-1-azabicyclo[3.2.0]hept-3-yl]-, methyl ester, [3S-(3α,5α,6β)]- (9CI) |
C29H28N6O3S |
| 1133206-74-2 |
NVP-BEZ 235-D3 |
NVP-BEZ 235-D3 |
C30H23N5O |
| 1133208-42-0 |
维格列汀D7 |
Vildagliptin D7 |
C17H25N3O2 |
| 113321-22-5 |
|
methyl, [[]3-(acetylamino)phenyl] |
C9H10NO* |
| 113321-58-7 |
|
Butanedioic acid, 2,3-bis(phenylmethoxy)-, 1,4-diethyl ester, (2S,3S) |
C22H26O6 |
| 113321-96-3 |
氟咯草酮衍生物-3-羟基取代 |
2-Pyrrolidinone, 4-(chloromethyl)-3-hydroxy-1-[3-(trifluoromethyl)phenyl] |
C12H11ClF3NO2 |
| 1133210-23-7 |
(R)-Cetirizine-d4 Dihydrochloride |
(R)-Cetirizine-d4 Dihydrochloride |
C21H25ClN2O3 |
| 1133211-71-8 |
|
SodiuM 5-Methylbenzo[d][1,3]dioxole-4-carboxylate |
C8H7NaO4 |
| 113322-78-4 |
|
Benzeneacetic acid, α,2-dihydroxy-α,4-dimethyl-, ethyl ester, (R)- (9CI) |
C12H16O4 |
| 113322-99-9 |
|
Carbamic acid, N-[(1S,2R)-2-hydroxy-1-methyl-2-phenylethyl]-, 1,1-dimethylethyl ester |
C14H21NO3 |
| 1133229-29-4 |
Levetiracetam-d6 [2,3,3,4,4,4-bu1yramide-d6) |
Levetiracetam-d6 [2,3,3,4,4,4-bu1yramide-d6) |
C8H14N2O2 |
| 1133229-30-7 |
左乙拉西坦杂质-d6 |
LEVETIRACETAM-D6 |
C8H8D6N2O2 |
| 113323-39-0 |
泰妙菌素杂质E |
TiaMulin IMpurity E (TiaMulone,11-Oxo TiaMulin) |
C28H45NO4S |
| 1133256-82-2 |
|
2-[(5-Methyl-1,3-oxazol-2-yl)methyl]-2,3-dihydro-1H-isoindole-1,3-dione |
C13H10N2O3 |
| 1133314-10-9 |
3-溴-4-(3-甲氧基-3-氧代丙基)苯甲酸甲酯 |
Methyl 3-broMo-4-(3-Methoxy-3-oxopropyl)benzoate |
C12H13BrO4 |
| 113332-25-5 |
Nimbidiol |
Nimbidiol |
C17H22O3 |
| 113332-46-0 |
1-[(Phenylmethoxy)carbonyl]-L-prolyl-β-alanine |
1-[(Phenylmethoxy)carbonyl]-L-prolyl-β-alanine |
C16H20N2O5 |
| 1133325-57-1 |
1133325-57-1 |
(1R,5S)-tert-butyl 7-oxo-6-((S)-1-phenylethyl)-2,6-diaza-bicyclo[3.2.0]heptane-2-carboxylate |
C18H24N2O3 |
| 113333-46-3 |
|
1-Penten-4-yne, 5-iodo |
C5H5I |
| 113334-45-5 |
|
4-{(1E)-1-[2-(1,3-benzothiazol-2-yl)hydrazinylidene]ethyl}phenol |
C15H13N3OS |
| 113334-58-0 |
2-(3-羟基苯基)噻唑-4-甲酸 |
2-(3-Hydroxyphenyl)thiazole-4-carboxylic Acid |
C10H7NO3S |
| 113334-60-4 |
2-(4-羟基苯基)-4-噻唑羧酸乙酯 |
4-Thiazolecarboxylic acid, 2-(4-hydroxyphenyl)-, ethyl ester |
C12H11NO3S |
| 113334-98-8 |
|
1-Penten-3-ol, 1-phenyl-, 3-acetate, (1E) |
C13H16O2 |
| 113335-42-5 |
|
Phosphine, 1,3-propanediylbis[2-propenyl- (9CI) |
C9H18P2 |
| 1133352-80-3 |
|
Ethanone, 1-[3-(β-D-glucopyranosyloxy)-5-hydroxyphenyl]- |
C14H18O8 |
| 1133355-98-2 |
Topotecan-d5 |
Topotecan-d5 |
C23H23N3O5 |
| 113336-22-4 |
1H-吡唑-1-乙腈 |
1H-pyrazol-1-ylacetonitrile |
C5H5N3 |
| 113336-23-5 |
2-(4-氯-1H-吡唑-1-基)乙腈 |
(4-chloro-1H-pyrazol-1-yl)acetonitrile |
C5H4ClN3 |
| 113336-57-5 |
|
Benzeneacetamide, α-hydroxy-N-[1-(hydroxymethyl)-2-phenylethyl]-, [R-(R*,S*)]- (9CI) |
C17H19NO3 |
| 113337-37-4 |
|
Ethanone, 2-chloro-1-(2-nitrophenyl)- (9CI) |
C8H6ClNO3 |
| 113337-38-5 |
1-(3,4-二氯苯基)-2-羟基-1-乙酮 |
1-(3,4-DICHLOROBENZYL)-1H-INDOLE-2,3-DIONE |
C8H6Cl2O2 |
| 113337-46-5 |
|
2-Propenoic acid, 2-methoxy-3-(3-methylphenyl)-, methyl ester, (Z)- (9CI) |
C12H14O3 |
| 1133378-37-6 |
九氘代地瑞拉为 |
Darunavir-D9 |
C27H37N3O7S |
| 1133378-83-2 |
Tafenoquine-d3 Succinate |
Tafenoquine-d3 Succinate |
C28H34F3N3O7 |
| 113338-78-6 |
|
2-Propenoicacid,2-methyl-,1-methyl-1,3-propanediylester,polymerwithbutyl2-propenoate,2-propenenitrileand2-propenoicacid |
C25H37NO8 |
| 1133384-24-3 |
Benzoic acid, 4,4',4''-[(2,4,6-trimethyl-1,3,5-benzenetriyl)tri-2,1-ethynediyl]tris- |
Benzoic acid, 4,4',4''-[(2,4,6-trimethyl-1,3,5-benzenetriyl)tri-2,1-ethynediyl]tris |
C36H24O6 |
| 1133387-60-6 |
阿瑞匹坦-d4 |
Aprepitant-d4 |
C23H17D4F7N4O3 |
| 1133387-90-2 |
|
2-AAPA |
C18H22N4O6S4 |
| 113340-06-0 |
|
6-Oxa-7-azabicyclo[3.2.2]non-8-ene |
C7H11NO |
| 113340-18-4 |
|
2-Cyclohepten-1-ol, 4-amino-, cis- (9CI) |
C7H13NO |
中文
